Cenegermin: A Review in Neurotrophic Keratitis
Sign Up to like & getrecommendations! Published in 2020 at "Drugs"
DOI: 10.1007/s40265-020-01289-w
Abstract: Cenegermin (Oxervate™), an ophthalmic solution containing 20 µg/mL of recombinant human nerve growth factor (rhNGF), is the first drug to be approved for the treatment of neurotrophic keratitis (NK; also referred to as neurotrophic keratopathy). In… read more here.
Keywords: neurotrophic keratitis; cenegermin review; treatment; corneal healing ... See more keywords
Topical cenegermin 0.002% for pediatric neurotrophic keratopathy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Ophthalmology"
DOI: 10.1177/11206721221094783
Abstract: Purpose To evaluate the efficacy and safety of cenegermin 0.002% ophthalmic drops in the management of pediatric neurotrophic keratopathy (NK). Methods Retrospective chart review of children under the age of 18 years diagnosed with NK… read more here.
Keywords: cenegermin; neurotrophic keratopathy; cenegermin 002; therapy ... See more keywords